Mainz BioMed N.V., corporate

Mainz BioMed N.V.,

05.01.2022 - 09:04:56

Mainz Biomed Acquires Exclusive Rights to Novel mRNA Biomarkers

05.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at

Language: English Company: Mainz BioMed N.V. Robert-Koch-Strasse 50 55129 Mainz

Germany Internet: EQS News ID: 1264870 ? End of News DGAP News Service